This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pearson, P. J. Articles by Schaff, H. V. Search for Related Content PubMed PubMed Citation Articles by Pearson, P. J. Articles by Schaff, H. V.

Circulation, Vol 86, 289-294, Copyright © 1992 by American Heart Association

ARTICLES

Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization

PJ Pearson, PR Evora, K Ayrancioglu and HV Schaff
Cardiac Surgical Research, Mayo Clinic, Rochester, Minn 55905.

BACKGROUND. When used to reverse the anticoagulant effect of heparin, protamine sulfate often causes vasodilation that can lead to systemic hypotension. Protamine is rich in the basic amino acid arginine, which is the precursor of endothelial cell synthesis of nitric oxide, and nitric oxide is the active component of endothelium-derived relaxing factor (EDRF). METHODS AND RESULTS. To determine whether the hypotensive effect of protamine could be due to stimulated release of EDRF, we studied rings (4-5 mm) of canine coronary, femoral, and renal artery suspended in organ chambers containing physiological salt solution (37 degrees C and 95% O2-5% CO2). Arterial rings with and without endothelium were contracted with prostaglandin F2 alpha (2 x 10(-6) M) and exposed to increasing concentrations of protamine (final organ bath concentration, 40-400 micrograms/ml). In arterial segments without endothelium, protamine caused only a modest decrease in tension. However, protamine induced concentration-dependent relaxation in all arterial segments with endothelium, which was significantly greater than in segments without endothelium (p less than 0.05). The endothelium-dependent relaxation induced by protamine was inhibited by NG-monomethyl-L-arginine (L-NMMA) (10(-5) M), but L-NMMA had no effect on rings without endothelium. The action of L-NMMA could be reversed by L-arginine (10(-4) M) but not D-arginine (10(-4) M). CONCLUSIONS. This study demonstrates that protamine stimulates the release of EDRF from arterial endothelium, and that endothelium-dependent vasodilation may be an important cause of systemic hypotension during protamine infusion.

This article has been cited by other articles:

				D. Del Duca, S. S. Sheth, A. E. Clarke, K. J. Lachapelle, and P. L. Ergina Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin. Ann. Thorac. Surg., February 1, 2009; 87(2): 640 - 642. [Abstract] [Full Text] [PDF]

				Y. Hamada, Y. Kameyama, H. Narita, K. T. Benson, and H. Goto Protamine After Heparin Produces Hypotension Resulting from Decreased Sympathetic Outflow Secondary to Increased Nitric Oxide in the Central Nervous System Anesth. Analg., January 1, 2005; 100(1): 33 - 37. [Abstract] [Full Text] [PDF]

				M. Poullis, M. Shackcloth, P. R. B. Evora, and F. Viaro Catastrophic Cardiovascular Adverse Reactions to Protamine Chest, July 1, 2003; 124(1): 411 - 412. [Full Text] [PDF]

				I. Golbasi, C. Nacitarhan, S. Ozdem, C. Turkay, H. Karakaya, G. Sadan, and O. Bayezid The inhibitory action of protamine on human internal thoracic artery contractions: the effect of free hemoglobin Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 962 - 968. [Abstract] [Full Text] [PDF]

				F. Viaro, M. B. Dalio, and P. R. B. Evora MD Catastrophic Cardiovascular Adverse Reactions to Protamine Are Nitric Oxide/Cyclic Guanosine Monophosphate Dependent and Endothelium Mediated* : Should Methylene Blue Be the Treatment of Choice? Chest, September 1, 2002; 122(3): 1061 - 1066. [Abstract] [Full Text] [PDF]

				D. Pevni, I. Frolkis, A. Iaina, Y. Wollman, T. Chernichovski, I. Shapira, G. Uretzky, and R. Mohr Protamine cardiotoxicity and nitric oxide Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 147 - 152. [Abstract] [Full Text] [PDF]

				J.-S. David, B. Vivien, Y. Lecarpentier, P. Coriat, and B. Riou Extracellular Calcium Modulates the Effects of Protamine on Rat Myocardium Anesth. Analg., April 1, 2001; 92(4): 817 - 823. [Abstract] [Full Text] [PDF]

				D. Pevni, J. Gurevich, I. Frolkis, G. Keren, I. Shapira, J. Paz, A. Kramer, C. Locker, and R. Mohr Protamine induces vasorelaxation of human internal thoracic artery by endothelial NO-synthase pathway Ann. Thorac. Surg., December 1, 2000; 70(6): 2050 - 2053. [Abstract] [Full Text] [PDF]

				S. E. Kimmel, M. A. Sekeres, J. A. Berlin, N. Ellison, V. J. DiSesa, and B. L. Strom Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1916 - 1922. [Abstract] [Full Text] [PDF]

				P. J. Pearson and H. V. Schaff Effects of cardioplegic solutions on vasoreactivity of the internal mammary artery Ann. Thorac. Surg., August 1, 1998; 66(2): 311 - 312. [Full Text] [PDF]

				S. C. Body and S. K. Shernan The Utility of Nitric Oxide in the Postoperative Period Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 4 - 30. [Abstract] [PDF]

				R. O. Han, D. S. Ettenson, E. W. Y. Koo, and E. R. Edelman Heparin/heparan sulfate chelation inhibits control of vascular repair by tissue-engineered endothelial cells Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2586 - H2595. [Abstract] [Full Text] [PDF]

				X.-H. Ning, Keith.F. Childs, and S. F. Bolling Glucose Level and Myocardial Recovery After Warm Arrest Ann. Thorac. Surg., December 1, 1996; 62(6): 1825 - 1829. [Abstract] [Full Text]

				R. B. Hird, T. W. Wakefield, R. Mukherjee, B. U. Jones, F. A. Crawford, P. C. Andrews, J. C. Stanley, and F. G. Spinale Direct Effects of Protamine Sulfate on Myocyte Contractile Processes : Cellular and Molecular Mechanisms Circulation, November 1, 1995; 92(9): 433 - 446. [Abstract] [Full Text]

				P. R. B. Evora, P. J. Pearson, and H. V. Schaff Protamine Induces Endothelium-Dependent Vasodilatation of the Pulmonary Artery Ann. Thorac. Surg., August 1, 1995; 60(2): 405 - 410. [Abstract] [Full Text]

				S. E. Fremes, R. D. Furukawa, J. Zhang, R.-K. Li, L. C. Tumiati, R. D. Weisel, and D. A. G. Mickle Cardiac Storage With University of Wisconsin Solution and a Nucleoside-Transport Blocker Ann. Thorac. Surg., May 1, 1995; 59(5): 1127 - 1133. [Abstract] [Full Text]

				M. Friedman, R. G. Johnson, S. Y. Wang, H. B. Dai, R. L. Thurer, R. M. Weintraub, and F. W. Sellke Pulmonary microvascular responses to protamine and histamineEffects of cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1092 - 1099. [Abstract] [Full Text]